This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_EAR_RESP_EXALLC for full statistics.
Carcinoma in situ of middle ear and respiratory system
CD2_INSITU_EAR_RESP
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
83 |
4. Check minimum number of eventsNone |
83 |
5. Include endpoints |
165 |
6. Filter based on genotype QC (FinnGen only) |
165 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ auris mediae sive systematis respiratorii
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of middle ear and respiratory system
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of middle ear and respiratory system
- In situ neoplasms
- In situ neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 165 | 44 | 121 |
| Unadjusted period prevalence (%) | 0.04 | 0.01 | 0.05 |
| Median age at first event (years) | 68.56 | 66.30 | 69.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 158
- Matched controls
- 1581
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D02.0
ICD-10 Finland
Carcinoma in situ: Larynx
+∞
52.0
47
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
214.2
46.6
46
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
58.2
39.9
46
11
DQA10
NOMESCO Finland
Biopsy of larynx
73.4
27.1
30
5
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
61.2
26.3
30
6
ZXC10
NOMESCO Finland
Use of laser
34.6
24.3
31
11
UDQ12
NOMESCO Finland
Flexible laryngoscopy
15.8
24.0
40
33
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
84.4
20.3
22
*
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
20.2
19
*
J38.3
ICD-10 Finland
Other diseases of vocal cords
53.4
19.8
23
5
UDQ22
NOMESCO Finland
Microlaryngoscopy
60.1
18.5
21
*
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
75.7
18.2
20
*
8070/2-C32.0
ICD-O-3
Squamous cell carcinoma in situ, NOS, of glottis
+∞
18.1
17
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.2
16.9
50
109
8140/2-C34.1
ICD-O-3
Adenocarcinoma in situ, NOS, of upper lobe, lung
+∞
15.9
15
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.3
15.3
44
91
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
+∞
14.8
14
*
C320, 8077, 2
ICD-O-3
NA
+∞
14.8
14
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
9.5
14.4
30
38
J37.0
ICD-10 Finland
Chronic laryngitis
14.0
13.6
23
19
WF002
NOMESCO Finland
Radical radiotherapy
8.1
13.5
31
46
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
19.4
12.9
19
11
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
25.2
11.8
16
7
D02.3
ICD-10 Finland
Carcinoma in situ: Other parts of respiratory system
+∞
11.6
11
*
D02.2
ICD-10 Finland
Carcinoma in situ: Bronchus and lung
+∞
11.6
11
*
DQB70
NOMESCO Finland
Total excision of vocal cord
+∞
11.6
11
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.9
11.1
32
65
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
64.5
10.8
12
*
130
Kela drug reimbursment
Malignant tumour
4.7
10.3
37
97
GD1AD
NOMESCO Finland
Thorax CT examination
10.6
10.1
19
20
UJC01
NOMESCO Finland
Scopy of lower throat
21.8
10.0
14
7
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.1
9.9
22
31
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.3
9.4
25
46
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.3
9.4
22
34
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
9.3
70
329
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
20.1
9.1
13
7
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
15.2
8.9
14
10
2310A
ICD-9 Finland
Carcinoma in situ of respiratory system, Larynx
+∞
8.4
8
*
DQB30
NOMESCO Finland
Laryngectomy
+∞
8.4
8
*
WX734
NOMESCO Finland
JET-ventilation
83.9
7.5
8
*
UDQ02
NOMESCO Finland
Direct laryngoscopy
83.9
7.5
8
*
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
83.9
7.5
8
*
8070/2-C32.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of larynx, NOS
+∞
7.3
7
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
16.8
7.3
11
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
6.9
42
168
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.1
6.7
38
145
WZC30
NOMESCO Finland
Teaching
3.5
6.7
31
102
UJC02
NOMESCO Finland
Rigid oesophagoscopy
72.7
6.5
7
*
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
+∞
6.3
6
*
8070/2-C34.3
ICD-O-3
Squamous cell carcinoma in situ, NOS, of lower lobe, lung
+∞
6.3
6
*
8140/2-C34.3
ICD-O-3
Adenocarcinoma in situ, NOS, of lower lobe, lung
+∞
6.3
6
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.0
6.2
16
29
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
6.1
54
266
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
36
114
3.76
10.05
1.7
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
17
8.22
9.41
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
82
474
2.45
7.38
3.8
2.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
36
4.81
6.87
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
34
136
2.89
6.37
1.2
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
53
3.69
5.48
2.5
3.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
41
199
2.41
5.17
1.8
2.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
19
5.54
5.11
2.8
3.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
86
582
2.00
4.56
11.7
9.2
inr
1.3
1.3
0.14
21
165
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
26
4.46
4.43
1.5
1.7
ug/l
14.4
14.4
0.00
11
26
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
26
4.03
3.58
1.7
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
66
438
1.84
3.48
4.3
3.3
mmol/l
2.3
2.3
0.22
58
370
(3044640) Blood type and Crossmatch panel - Blood
63
420
1.81
3.23
2.9
2.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
16
5.20
3.09
1.9
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
88
656
1.73
3.01
7.3
7.0
mmol/l
1.2
1.2
0.03
79
547
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
35
3.30
2.99
1.5
1.9
—
—
—
0
0
(3019225) pH of Specimen
27
141
2.09
2.81
3.3
4.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
79
582
1.69
2.75
4.9
4.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
37
3.11
2.75
1.5
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
19
4.37
2.71
1.1
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
15
4.82
2.62
1.9
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
74
541
1.67
2.62
5.1
5.4
%
63.0
58.4
2.71
69
504
(3013650) Neutrophils [#/volume] in Blood by Automated count
89
686
1.65
2.54
11.2
10.3
e9/l
4.6
4.3
0.53
81
597
(3022096) Basophils/100 leukocytes in Blood
72
529
1.64
2.46
5.2
5.6
%
0.7
0.6
0.44
67
490
(3006504) Eosinophils/100 leukocytes in Blood
73
540
1.63
2.42
5.2
5.6
%
2.6
2.7
0.11
68
499
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
35
2.98
2.35
1.7
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
74
554
1.61
2.31
5.3
5.7
%
22.3
25.7
2.29
67
511
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
23
3.60
2.30
1.8
1.4
—
—
—
0
0
(4010399)
19
94
2.15
2.26
1.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
308
1.68
2.22
3.3
2.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
79
608
1.57
2.16
6.8
6.2
mmol/l
1.2
1.2
0.44
73
539
(3019069) Monocytes/100 leukocytes in Blood
72
543
1.58
2.15
5.4
5.8
%
9.6
9.0
0.82
67
505
(3000492) Spirometry study
17
83
2.17
2.10
1.6
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
10
5.12
2.08
2.4
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
11
4.65
1.95
2.4
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
75
581
1.53
1.94
4.7
5.5
e9/l
0.7
0.6
1.94
66
496
(3006315) Basophils [#/volume] in Blood
75
583
1.53
1.90
4.7
5.5
e9/l
0.0
0.0
0.73
66
502
(3019198) Lymphocytes [#/volume] in Blood
76
593
1.52
1.89
4.9
5.6
e9/l
1.7
1.8
0.46
68
523
(3023368) Bacteria identified in Blood by Culture
59
438
1.54
1.83
4.6
4.5
—
—
—
0
0
(3002256) Pathology report gross observation
26
157
1.78
1.79
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
96
1.98
1.79
2.3
3.9
%
0.0
0.1
—
8
36
(3017181) Myelocytes/100 leukocytes in Blood
19
104
1.93
1.76
2.4
3.7
%
0.4
1.0
—
8
41
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
14
3.65
1.62
2.2
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
162
1.72
1.62
6.9
4.8
ug/l
5.4
47.3
0.79
26
137
(42870588) Differential panel, method unspecified - Blood
56
421
1.50
1.61
4.6
5.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
43
306
1.55
1.59
5.1
4.0
%
91.7
84.7
1.02
43
300
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
64
498
1.47
1.55
2.8
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
99
838
1.45
1.53
4.8
4.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
16
87
1.93
1.52
2.6
4.1
%
0.0
0.3
—
7
30
(3007853) Bacteria identified in Skin by Aerobe culture
24
149
1.71
1.51
1.5
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
75
604
1.44
1.51
4.9
5.7
e9/l
0.2
0.2
0.17
69
527
(40760892) CBC W Ordered Manual Differential panel - Blood
34
233
1.58
1.48
4.1
5.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
16
88
1.91
1.47
2.6
3.7
%
0.0
0.4
—
5
25
(3022806) Fractional oxyhemoglobin in Capillary blood
6
22
2.79
1.45
1.5
1.9
%
86.4
90.3
—
6
22
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
11
53
2.15
1.42
3.8
2.8
pmol/l
4.1
4.1
0.02
11
44
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
153
1.67
1.38
1.8
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
24
2.55
1.31
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
34
2.42
1.31
2.0
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
93
1.80
1.26
2.5
3.3
ml/min/173m2
56.0
58.2
—
6
40
(1616796) Gas panel - Central venous blood
8
36
2.28
1.26
6.0
2.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
50
385
1.43
1.24
4.3
4.4
ph
7.4
7.4
0.41
14
80
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
32
226
1.52
1.22
2.3
2.0
—
—
—
0
0
(1002224) Polysomnography panel
6
26
2.36
1.19
1.2
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
26
2.36
1.19
1.7
3.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
26
2.36
1.19
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
46
355
1.41
1.12
3.0
3.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
32
231
1.48
1.11
3.1
1.9
s
30.2
29.8
0.12
32
221
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
155
1.56
1.08
1.9
1.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
17
106
1.67
1.08
2.2
3.2
kpa
4.6
4.2
0.29
17
99
(3037756) Immunofixation for Serum or Plasma
7
35
2.04
1.01
1.0
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
32
0.00
0.96
0.0
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
81
699
1.31
0.94
4.9
3.2
u/l
62.7
59.2
0.12
73
637
(3028271) Lactate [Moles/volume] in Capillary blood
6
27
2.27
0.94
2.3
2.0
mmol/l
1.7
1.8
—
6
27
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
94
830
1.31
0.92
5.0
3.6
pmol/l
15.6
15.1
1.00
85
717
(3018095) Leukocytes [#/volume] in Urine
57
473
1.31
0.87
3.2
4.0
e6/l
346.5
63.0
0.75
42
351
(3002582) Erythrocytes [#/volume] in Urine
51
421
1.31
0.80
3.0
3.4
e6/l
118.6
221.0
0.27
41
329
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.3
—
1.7
—
0
7
(3019060) Gas panel - Arterial blood
17
116
1.52
0.78
4.9
4.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
37
293
1.34
0.77
2.9
2.6
e6/l
7.6
4.0
0.42
32
252
(3027945) Reticulocytes/100 erythrocytes in Blood
25
186
1.41
0.76
2.0
2.4
%
1.6
1.8
0.64
25
162
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
60
1.71
0.74
1.7
2.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
25
2.03
0.73
1.2
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
25
2.03
0.73
1.2
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
26
1.95
0.71
2.4
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
69
1.64
0.70
3.2
2.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
27
1.88
0.69
2.2
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
27
1.88
0.69
1.2
4.7
%
1.0
1.3
—
5
21
(3009508) Creatinine [Moles/volume] in Urine
47
392
1.28
0.68
3.3
3.1
mmol/l
7.4
7.3
0.06
36
311
(3013512) EKG study
51
430
1.27
0.68
6.1
4.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
25
190
1.37
0.68
4.4
4.8
%
32.5
32.1
0.05
17
124
(3021589) Normoblasts [#/volume] in Blood
59
508
1.25
0.66
14.2
11.3
e9/l
0.0
0.0
0.45
43
417
(3026008) Bacteria identified in Urine by Culture
47
394
1.27
0.65
3.1
3.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
104
1.49
0.65
1.6
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
29
1.75
0.64
2.2
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
137
0.64
0.64
1.6
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
17
122
1.44
0.63
1.6
3.3
g/l
68.1
66.1
0.62
17
110
(3017143) Hepatitis C virus Ab [Presence] in Serum
13
88
1.52
0.62
1.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
30
1.69
0.62
1.4
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
45
379
1.26
0.60
3.1
3.2
e6/l
1.4
0.4
0.56
36
288
(3012516) Albumin [Mass/volume] in Urine
46
389
1.25
0.59
3.4
3.1
mg/l
42.2
218.2
0.56
29
255
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
8
53
1.53
0.59
2.1
3.4
g/l
41.7
37.2
—
8
46
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
81
1.52
0.59
11.2
8.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
60
1.53
0.55
1.9
3.1
g/l
8.6
10.5
—
9
53
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
61
1.50
0.55
1.9
3.1
g/l
2.9
3.1
—
9
50
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
48
553
0.81
0.54
5.8
4.7
%
22.7
21.0
0.34
31
282
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
65
1.41
0.51
1.9
3.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
65
1.41
0.51
1.9
3.0
g/l
3.4
3.8
—
9
49
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
65
1.41
0.51
1.9
3.0
g/l
7.1
7.5
—
9
51
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
109
0.63
0.50
1.4
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
34
402
0.81
0.49
3.4
3.2
ug/l
0.9
0.8
0.34
26
285
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
62
552
1.20
0.49
2.4
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
23
183
1.30
0.48
8.3
7.1
mmol/l
3.5
0.9
2.18
18
146
(3020682) Albumin/Creatinine [Ratio] in Urine
48
418
1.21
0.47
4.6
3.9
mg/mmol
3.1
7.8
1.59
28
269
(3011397) Hemoglobin [Presence] in Urine by Test strip
22
273
0.78
0.47
3.5
4.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
84
0.58
0.47
3.6
2.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
49
1.45
0.46
1.7
5.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
112
1.37
0.46
4.5
4.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
31
1.63
0.43
2.2
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
31
1.63
0.43
5.8
2.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
8
57
1.42
0.43
2.1
3.3
g/l
1.3
0.3
—
8
50
(40760888) Immunoglobulin light chains.free panel - Serum
5
32
1.58
0.42
1.6
4.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
58
1.40
0.42
1.8
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
41
358
1.19
0.39
1.4
1.7
nmol/l
20.8
21.4
0.09
33
297
(3022313) Gas panel - Capillary blood
11
80
1.40
0.39
2.7
3.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
122
1164
1.18
0.39
25.8
18.2
mg/l
30.2
27.4
0.42
111
969
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
64
582
1.16
0.38
5.5
4.4
ng/l
52.5
42.9
0.20
55
447
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
111
1052
1.17
0.38
6.0
4.4
mu/l
1.9
2.0
0.13
99
914
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
61
554
1.16
0.37
2.2
2.1
pmol/l
102.7
94.0
0.85
42
296
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
124
0.71
0.36
1.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
110
1154
0.86
0.36
5.3
5.5
mmol/l
2.4
2.6
1.36
100
1036
(3021601) Nitrite [Presence] in Urine by Test strip
64
584
1.16
0.36
5.5
5.5
estimate
0.0
0.0
0.00
18
115
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
103
1085
0.87
0.36
4.4
4.4
mmol/l
1.3
1.3
0.15
92
965
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
54
487
1.16
0.36
1.8
2.2
nmol/l
84.9
76.5
0.76
47
418
(3013707) Erythrocyte sedimentation rate by Westergren method
94
883
1.15
0.35
5.1
4.1
mm/h
15.5
14.0
0.34
84
800
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
43
1.41
0.35
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
30
347
0.83
0.35
3.8
3.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
164
1.25
0.34
6.0
3.7
—
—
—
0
0
(3044889) 12 lead EKG panel
90
844
1.15
0.34
5.0
4.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
35
306
1.18
0.33
2.0
1.7
nmol/l
1184.5
1138.6
0.14
30
225
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
107
1121
0.87
0.33
4.7
4.9
mmol/l
1.4
1.4
0.26
97
1005
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
12
153
0.77
0.32
1.2
1.3
u/ml
54.1
6.0
—
5
54
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
54
492
1.15
0.31
3.5
3.3
ng/l
743.3
1535.3
1.89
47
415
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
94
1.30
0.29
1.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
120
0.74
0.28
1.2
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
37
330
1.16
0.28
4.7
3.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
95
1.28
0.27
1.4
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
64
596
1.12
0.26
4.0
4.1
estimate
0.0
0.0
0.00
17
107
(3035350) Ketones [Presence] in Urine by Test strip
63
588
1.12
0.24
4.0
4.1
estimate
0.0
0.0
0.00
17
115
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
26
294
0.86
0.24
2.0
1.8
pmol/l
426.6
453.3
0.16
20
242
(3052851) Hemolysis interference index of Serum or Plasma
5
39
1.29
0.23
2.6
3.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
166
0.83
0.21
1.1
1.2
iu/ml
48.0
47.0
—
6
57
(3028626) Oxygen [Partial pressure] in Capillary blood
5
42
1.20
0.21
5.8
2.2
kpa
7.5
8.1
—
5
33
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
11
0.00
0.21
0.0
2.0
—
2.5
—
0
11
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
11
0.00
0.21
0.0
2.0
—
1.5
—
0
11
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
17
197
0.85
0.21
1.2
1.4
g/l
2.7
2.6
0.12
12
114
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
109
1126
0.91
0.20
4.7
4.9
mmol/l
4.3
4.4
0.22
99
1020
(3017446) Testosterone [Moles/volume] in Serum or Plasma
12
100
1.22
0.18
1.7
1.9
nmol/l
7.4
12.6
1.87
12
86
(3025941) Bacteria identified in Stool by Culture
5
66
0.75
0.17
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
68
1.19
0.17
2.0
4.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
72
1.12
0.16
2.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
77
0.77
0.16
2.2
2.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
49
462
1.09
0.15
4.8
4.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
117
1142
1.08
0.14
5.6
5.1
mmol/l
6.3
6.2
0.61
106
1020
(40768797) Stomach Pathology biopsy report
19
171
1.13
0.13
1.5
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
37
347
1.09
0.12
4.3
4.2
estimate
0.0
0.0
0.00
14
104
(3026493) Urate [Moles/volume] in Serum or Plasma
36
338
1.08
0.12
2.3
3.0
umol/l
356.9
7421.7
1.50
28
281
(40761535) Cells panel - Urine sediment
13
115
1.14
0.11
4.0
3.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
44
1.14
0.10
5.8
2.4
mmol/l
25.5
24.1
—
5
32
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
29
272
1.08
0.10
2.0
1.7
mg/l
1.1
1.5
0.73
22
214
(40768800) Prostate Pathology biopsy report
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
47
1.07
0.09
2.2
4.3
mg/l
22.4
35.9
—
5
37
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
47
1.07
0.09
2.2
4.3
mg/l
45.4
231.0
—
5
36
(40758558) Short blood count panel - Blood
31
292
1.08
0.09
6.6
7.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
31
293
1.07
0.08
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
6
58
1.04
0.08
3.3
4.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
60
0.83
0.08
2.6
4.1
u/ml
10.4
1453.8
—
5
51
(3030981) Hyaline casts [#/volume] in Urine by Automated count
10
88
1.15
0.08
1.7
3.4
e6/l
0.7
0.2
—
10
88
(3022217) INR in Platelet poor plasma by Coagulation assay
20
215
0.92
0.08
25.7
25.8
inr
1.3
1.4
—
7
21
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
24
225
1.08
0.08
2.2
2.9
e6/l
1.3
0.9
0.18
15
133
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
84
1.08
0.07
1.9
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
112
1103
1.05
0.07
24.6
17.0
ml/min/173m2
74.6
73.6
0.20
100
897
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
102
0.88
0.06
2.1
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
16
172
0.92
0.06
5.1
9.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
98
967
1.03
0.04
24.2
19.3
%
38.5
38.5
0.01
50
599
(3014576) Chloride [Moles/volume] in Serum or Plasma
20
191
1.05
0.03
6.5
7.0
mmol/l
104.1
104.2
0.07
20
186
(3000991) Gas panel - Venous blood
13
123
1.06
0.01
9.1
8.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
21
209
1.01
0.00
2.0
2.4
g/l
2.2
2.3
0.14
21
191
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
219
1.01
0.00
2.2
3.2
e6/l
1.6
1.7
0.00
13
129
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
110
1102
0.99
0.00
8.2
6.5
mmol/mol
41.6
41.3
0.12
99
1010
(40761511) CBC panel - Blood by Automated count
119
1185
1.02
0.00
26.3
16.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
70
699
1.00
0.00
5.9
5.5
ug/l
2.3
2.8
0.48
61
606
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
1.1
—
0
6
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
152.0
—
0
6
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
8
0.00
0.00
0.0
2.0
—
7.0
—
0
8
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
30.7
—
0
6
(3028707) Methadone [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
3.2
—
1950.0
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
60
1.00
0.00
1.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
19.7
—
0
8
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
282.4
—
0
5
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.1
—
6.3
—
0
8
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.8
—
0
6
(4015189)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_EAR_RESP – Carcinoma in situ of middle ear and respiratory system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).